DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Kovac M. et al.
Factor V Leiden mutation and high FVIII are associated with an increased risk of VTE in women with breast cancer during adjuvant tamoxifen - results from a prospective, single center, case control study.
Eur J Intern Med 2015;
26: 63-67.
We do not assume any responsibility for the contents of the web pages of other providers.